The Minister’s address was particularly notable for the announcement of a planned rollout of lenacapavir, a biannual ...

Gilead has partnered with Global Fund to supply lenacapavir for the prevention of HIV as pre-exposure prophylaxis (PrEP).

HIV jab has signed a deal to supply the costly injection at a knock-down price to as many as two million people in poorer countries.

The first lenacapavir jabs will be delivered later this year under a new agreement between Gilead Sciences and the Global Fund ...

Note that some links may require registration or subscription. The Department of Justice said it sent more than 20 subpoenas to doctors and clinics involved with transgender medical procedures on ...

UN officials warned that if the funding is not replaced, the world will see more than 4 million AIDS-related deaths and another 6 million HIV infections by 2029 ...

Through a strategic, non-profit agreement, Gilead will supply up to two million doses of the long-acting HIV prevention drug ...

National Treasury has allocated R753 million to the Department of Health -- under Section 16 of the Public Finance Management ...

While the National Treasury has released R700m, the Bill and Melinda Gates Foundation and the Wellcome Trust will ...

We also do home visits to make sure that the mothers take their medication on time, and to look after their babies when they ...

South Africa will be among the first countries in the world to receive doses of lenacapavir, the long-acting HIV prevention drug administered once every six months. This was announced by health ...

In early 2025, the US decision to halt foreign aid for HIV/AIDS programs triggered global concerns about a potential ...